NCT04967833View on ClinicalTrials.gov

Study on TIL for the Treatment of Advanced Solid Tumors

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 22, 2021

Primary Completion Date

December 22, 2025

Study Completion Date

April 22, 2026

Conditions
Advanced Solid Tumors
Interventions
BIOLOGICAL

Tumor Infiltrating Lymphocytes (TIL)

Biological: Tumor Infiltrating Lymphocytes (TIL) Adoptive transfer of 1x10\^9-5x10\^10 autologous TILs to patients i.v. in 30-120 minutes.

Trial Locations (1)

Unknown

RECRUITING

Tongren Hospital Shanghai Jiao Tong University School Of Medicine., Shanghai

All Listed Sponsors
collaborator

Shanghai Tong Ren Hospital

OTHER

lead

Shanghai Juncell Therapeutics

INDUSTRY